Standing out from the crowd illustration. Businessman thinking twice about following the crowd over a cliff. Files included – jpg, ai (version 8 and CS3), svg, and eps (version 8) While common sense ...
CAS and ACROBiosystems recently published new research in the Nature journal focussed on the COVID-19 Omicron variant. The paper is titled “Memory B cell repertoire from triple vaccines against ...
When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...
Monoclonal antibodies have proven to be a potent tool in our ability to prevent and treat SARS-CoV-2 infections. The current epidemic is driven in part by naturally occurring variants that elude ...
An HIV vaccine candidate developed at the Duke Human Vaccine Institute (DHVI) triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...
Researchers have developed a novel neutralizing agent, which becomes stronger as the coronavirus mutates. The emergence of unpredictable variants and their stronger infectivity make the COVID-19 ...
In a recent study published in PLOS Medicine, researchers evaluated the ability of vaccine-induced antibodies to recognize and neutralize various severe acute respiratory syndrome coronavirus 2 ...
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533 Vaccine-induced nAbs are detectable at much lower rates ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results